You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
It is possible that some of the products on the other site not be licensed for sale in Canada.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
By choosing to accept, you acknowledge that you are a Certified Healthcare Professional.
About the Therapy
Intrathecal baclofen therapy may reduce severe spasticity. The programmable pump delivers medication to where it’s needed – the spinal cord. This treatment option is adaptable, if necessary reversible, and non-destructive.
For spasticity of spinal origin, chronic infusion of baclofen via a drug delivery pump should be reserved for patients unresponsive to oral baclofen or those who experience intolerable side effects at effective doses.
Intrathecal baclofen therapy (ITB) therapy is a precise, targeted treatment that may reduce severe spasticity caused by multiple sclerosis.
All treatment and outcome results are specific to the individual patient, and will form part of your consultation with your healthcare professional.
Please consult your healthcare professional for a full list of benefits, indications, precautions, clinical results, and other important medical information that pertains to ITB therapy.
Review some common questions and concerns about how a baclofen pump (ITB therapy) may help minimise severe spasticity caused by multiple sclerosis.
Intrathecal baclofen therapy is a treatment that may relieve some of the symptoms of severe spasticity.
A baclofen pump or ITB therapy (intrathecal baclofen therapy) may treat some of the symptoms of your severe spasticity.
Depending on your specific condition, a baclofen pump may impact your severe spasticity in different ways. Treatment may be even more effective when used in combination with physical, occupational, or speech therapy.
ITB therapy uses a surgically implanted programmable pump and catheter that delivers medication which helps relieve severe spasticity caused by multiple sclerosis. This medication is a liquid form of baclofen that goes directly into the intrathecal space where fluid flows around the spinal cord.
Because baclofen is delivered directly to where the spinal fluid, it relieves spasticity with smaller amounts of medication than when baclofen is taken orally. This method of delivery may help minimise side effects that can result from oral baclofen.
The ITB therapy system consists of:
A baclofen pump system includes a programmable pump and catheter that are surgically placed, usually just under the skin of the abdomen. The system delivers a liquid form of the drug baclofen directly to the fluid around the spinal cord, where it's needed most.
Most people report that the programmable pump is not uncomfortable or restrictive, and does not interfere with their movement. Depending on your body type, it may not show at all under regular clothes.
Because the drug is delivered directly to where it is needed in the spinal fluid, only minimal amounts circulate throughout the body in the blood. This helps minimise the possible side effects that often accompany oral baclofen.
While a baclofen pump won’t eliminate the primary source of your condition or cure your disease, it may help you manage your severe spasticity symptoms and might allow you to participate in daily activities that have become difficult or impossible.
Candidates for a baclofen pump (ITB therapy) must:
In addition, healthcare professionals may use the following criteria to determine if you are a candidate for ITB therapy:
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.